Literature DB >> 18479298

Comparison of an immuno-turbidometric method (STalia D-DI) with an established enzyme linked fluorescent assay (VIDAS) D-dimer for the exclusion of venous thromboembolism.

K Sukhu1, J Beavis, P M Baker, D M Keeling.   

Abstract

The use of d-dimer tests for the exclusion of venous thromboembolism is an important advance in clinical practice and also has economic benefits. The Stalia D-Di (Diagnostica Stago, Asnieres, France) is a semi automated system for the quantification of d-dimer using an immuno-turbidometric method incorporating a suspension of latex microparticles coated with two different monoclonal antibodies specifically targeted against human d-dimer fragments. Results are available rapidly in <10 min compared with 35 min for the established VIDAS D-dimer automated enzyme-linked immunosorbent assay (ELISA, BioMerieux, Basingstoke, UK). During November and December 2005, 100 consecutive patients attending the outpatient deep venous thrombosis (DVT) clinic were tested using the VIDAS D-dimer as part of the routine DVT investigation. Using the same samples, D-dimer estimation was also performed on the STalia D-Di for comparison. Across a wide range of data (Vidas 83-5656) and (STali <200->4000), there was good agreement between the two methods. Using cutoff's of 500 microg/l fibrinogen equivalent units (Keeling et al., 1999), 42% (42/100) patients were negative (<500) and 46% (46/100) were positive (>500) on both systems. Six per cent (6/100) were positive on the Vidas but negative on the STalia and another 6% (6/100) were positive on the STalia but negative on the Vidas. In conclusion, 88% (88/100) of patients showed agreement and in the other 12% (12/100), one had a DVT as identified by Compression ultrasonography (CUS). In this study, there were seven patients with a DVT as identified by CUS and they all scored as 'likely' on a pretest clinical probability score and so negative D-dimer would not be used clinically to rule out the disease. The Vidas is a well established instrument for D-dimer measurement in outpatient DVT clinics, and in this small study the STalia compares very well and therefore would fit into an outpatient setting for D-dimer measurement. But ideally a larger study would be required before implementing new methodology in a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479298     DOI: 10.1111/j.1751-553X.2007.00942.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  4 in total

1.  Fluorescence immunoassay of human D-dimer in whole blood.

Authors:  Tae Kyum Kim; Sang Wook Oh; Young Joon Mok; Eui Yul Choi
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

2.  Comments on point of care D-dimer testing in the emergency department: a bioequivalence study.

Authors:  Suzanne Ekelund; Eric Heilmann
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

3.  Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST.

Authors:  Ran Meng; Xiaoying Wang; Mohammed Hussain; David Dornbos; Lu Meng; Yu Liu; Yan Wu; Mingming Ning; Buonanno Ferdinando S; Eng H Lo; Yuchuan Ding; Xunming Ji
Journal:  Int J Stroke       Date:  2013-03-19       Impact factor: 5.266

4.  Response to the comments on 'point of care D-dimer testing in the emergency department--a bioequivalence study' and erratum to the results.

Authors:  Shuhana Perveen; Danielle Unwin; Amith L Shetty; Karen Byth
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.